Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Palatin Technologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Palatin Technologies Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Palatin Technologies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Palatin Technologies Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Palatin Technologies Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Palatin Technologies Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Palatin Secures USD10 Million Venture Loan from Horizon Technology Finance 11
Licensing Agreements 12
Kwang Dong Pharma Enters into Licensing Agreement with Palatin Technologies 12
Shanghai Fosun Pharma Enters into Licensing Agreement with Palatin Technologies 13
AMAG Pharma Enters into Licensing Agreement with Palatin Tech 14
Palatin Exercises Option For Licensing Agreement With European Specialty Pharmaceutical Company 16
Equity Offering 17
Palatin Technologies Plans to Raise USD100 Million in Public Offering of Securities 17
Palatin Technologies Plans to Raise up to USD25 Million in Public Offering of Shares 18
Palatin Technologies Raises USD16.5 Million in Public Offering of Units 19
Palatin Technologies Raises USD9.2 Million in Public Offering of Units 21
Palatin Raises USD20 Million in Private Placement of Warrants 23
Palatin Raises USD20 Million in Private Placement of Shares and Warrants 25
Palatin Technologies Completes Private Placement Of Common Stock And Warrants For US$35 Million 27
Palatin Technologies Inc – Key Competitors 28
Palatin Technologies Inc – Key Employees 29
Palatin Technologies Inc – Locations And Subsidiaries 30
Head Office 30
Other Locations & Subsidiaries 30
Recent Developments 31
Financial Announcements 31
Sep 13, 2018: Palatin Technologies reports fourth quarter and fiscal year 2018 results 31
May 15, 2018: Palatin Technologies Announces Third Quarter Fiscal Year 2018 Results 34
Feb 12, 2018: Palatin Technologies Reports Second Quarter Fiscal Year 2018 Results 36
Nov 13, 2017: Palatin Technologies reports first quarter fiscal year 2018 results 38
Sep 25, 2017: Palatin Technologies Reports Fourth Quarter and Fiscal Year 2017 Results; Teleconference and Webcast to be held on September 25, 2017 40
May 16, 2017: Palatin Technologies Reports Third Quarter Fiscal Year 2017 Results 42
Feb 09, 2017: Palatin Technologies Reports Second Quarter Fiscal Year 2017 Results 44
Corporate Communications 45
Sep 12, 2017: Palatin Technologies Announces Appointment of Anthony M. Manning, Ph.D. to Board of Directors 45
Product News 46
01/03/2018: Palatin Technologies Announces FDA Clearance of Investigational New Drug Application for PL-8177 For Ulcerative Colitis 46
Product Approvals 47
Jun 04, 2018: AMAG Pharmaceuticals Announces FDA Acceptance of New Drug Application Filing for Bremelanotide 47
Jun 04, 2018: Palatin Technologies Announces FDA Acceptance for Review of Bremelanotide NDA 49
Mar 26, 2018: AMAG Pharmaceuticals Submits a New Drug Application to the U.S. Food and Drug Administration for Bremelanotide for the treatment of Hypoactive Sexual Desire Disorder in Premenopausal Women 50
Clinical Trials 51
May 09, 2018: Palatin Technologies Presents Positive Preclinical Data on its Drug Candidate PL-8177at TIDES: Oligonucleotide and Peptide Therapeutics 2018 Meeting in Boston, Massachusetts 51
May 09, 2018: Palatin Technologies Presents Positive Preclinical Data on PL-8331 at TIDES: Oligonucleotide and Peptide Therapeutics 2018 Meeting in Boston, Massachusetts 52
Apr 03, 2018: Palatin Technologies presents preclinical oral formulation data on PL-8177, an investigational melanocortin receptor 1 Agonist for inflammatory bowel disease 53
Feb 05, 2018: Palatin Technologies, Inc. Initiates Subject Dosing in First-in-Human Clinical Study of PL-8177, an Investigational Melanocortin Receptor 1 Agonist 54
Feb 27, 2017: AMAG and Palatin Announce Rekynda Data Presentations at the International Society for the Study of Women’s Sexual Health Annual Meeting 55
Other Significant Developments 57
Jul 11, 2018: Horizon Technology Finance provides investment portfolio update 57
Appendix 59
Methodology 59
About GlobalData 59
Contact Us 59
Disclaimer 59
Palatin Technologies Inc, Pharmaceuticals & Healthcare, Key Facts, 2018 2
Palatin Technologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Palatin Technologies Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Palatin Technologies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Palatin Technologies Inc, Deals By Therapy Area, 2012 to YTD 2018 9
Palatin Technologies Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Palatin Secures USD10 Million Venture Loan from Horizon Technology Finance 11
Kwang Dong Pharma Enters into Licensing Agreement with Palatin Technologies 12
Shanghai Fosun Pharma Enters into Licensing Agreement with Palatin Technologies 13
AMAG Pharma Enters into Licensing Agreement with Palatin Tech 14
Palatin Exercises Option For Licensing Agreement With European Specialty Pharmaceutical Company 16
Palatin Technologies Plans to Raise USD100 Million in Public Offering of Securities 17
Palatin Technologies Plans to Raise up to USD25 Million in Public Offering of Shares 18
Palatin Technologies Raises USD16.5 Million in Public Offering of Units 19
Palatin Technologies Raises USD9.2 Million in Public Offering of Units 21
Palatin Raises USD20 Million in Private Placement of Warrants 23
Palatin Raises USD20 Million in Private Placement of Shares and Warrants 25
Palatin Technologies Completes Private Placement Of Common Stock And Warrants For US$35 Million 27
Palatin Technologies Inc, Key Competitors 28
Palatin Technologies Inc, Key Employees 29
Palatin Technologies Inc, Subsidiaries 30
List of Figures
Palatin Technologies Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Palatin Technologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Palatin Technologies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Palatin Technologies Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Palatin Technologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Palatin Technologies Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Palatin Technologies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Palatin Technologies Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9